Related Experiment Video
Updated: Jul 30, 2025

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
Published on: December 18, 2019
Expression of FBXW11 in normal and disease-associated osteogenic cells
Luca Dalle Carbonare1, Macarena Gomez Lira2, Arianna Minoia1
1Department of Medicine, University of Verona, Verona, Italy.
Abstract:
The ubiquitin-proteasome system (UPS) plays an important role in maintaining cellular homeostasis by degrading a multitude of key regulatory proteins. FBXW11, also known as b-TrCP2, belongs to the F-box family, which targets the proteins to be degraded by UPS. Transcription factors or proteins associated with cell cycle can be modulated by FBXW11, which may stimulate or inhibit cellular proliferation. Although FBXW11 has been investigated in embryogenesis and cancer, its expression has not been evaluated in osteogenic cells. With the aim to explore FBXW11gene expression modulation in the osteogenic lineage we performed molecular investigations in mesenchymal stem cells (MSCs) and osteogenic cells in normal and pathological conditions. In vitro experiments as well as ex vivo investigations have been performed. In particular, we explored the FBXW11 expression in normal osteogenic cells as well as in cells of cleidocranial dysplasia (CCD) patients or osteosarcoma cells. Our data showed that FBXW11 expression is modulated during osteogenesis and overexpressed in circulating MSCs and in osteogenically stimulated cells of CCD patients. In addition, FBXW11 is post-transcriptionally regulated in osteosarcoma cells leading to increased levels of beta-catenin. In conclusion, our findings show the modulation of FBXW11 in osteogenic lineage and its dysregulation in impaired osteogenic cells.
Insights
FBXW11 (b-TrCP2) expression changes during bone cell development and is elevated in mesenchymal stem cells and cleidocranial dysplasia patients, impacting cellular proliferation and homeostasis.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The ubiquitin-proteasome system (UPS) is crucial for cellular homeostasis through protein degradation.
- FBXW11 (b-TrCP2) is an F-box protein that targets proteins for UPS degradation, influencing cell cycle and proliferation.
- FBXW11's role in osteogenic cells remains largely unexplored despite its known involvement in embryogenesis and cancer.
Purpose of the Study:
- To investigate FBXW11 gene expression modulation within the osteogenic lineage.
- To analyze FBXW11 expression in normal and pathological osteogenic conditions, including mesenchymal stem cells (MSCs), cleidocranial dysplasia (CCD), and osteosarcoma.
Main Methods:
- In vitro and ex vivo molecular investigations were conducted.
- FBXW11 expression was analyzed in normal osteogenic cells, MSCs, and cells from CCD patients and osteosarcoma.
- Post-transcriptional regulation of FBXW11 and its effect on beta-catenin levels were examined in osteosarcoma cells.
Main Results:
- FBXW11 expression is modulated during osteogenesis.
- FBXW11 is overexpressed in circulating MSCs and in osteogenically stimulated cells from CCD patients.
- FBXW11 undergoes post-transcriptional regulation in osteosarcoma cells, leading to elevated beta-catenin levels.
Conclusions:
- FBXW11 expression is dynamically regulated throughout the osteogenic lineage.
- Dysregulation of FBXW11 is observed in impaired osteogenic cells, such as those from CCD patients and osteosarcoma.
- FBXW11 plays a significant role in osteogenesis and its aberrant expression contributes to pathological conditions.
Related Concept Videos
Bone Formation by Endochondral Ossification
Osteoclasts in Bone Remodeling
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
TGF - β Signaling Pathway
Growth of Cartilage and Bone Tissue

